Profund Advisors LLC Zai Lab LTD Transaction History

Profund Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$22.72 - $31.49 $21,106 - $29,254	929 Added 4.93%	19,777 $480,000
Q2 2023 Aug 10, 2023	SELL	$25.3 - $39.67 $58,240 - $91,320	-2,302 Reduced 10.88%	18,848 $522,000
Q1 2023 May 11, 2023	BUY	$30.21 - $48.1 $363,154 - $578,210	12,021 Added 131.68%	21,150 $703,000
Q4 2022 Feb 02, 2023	SELL	$22.28 - $38.71 $121,804 - $211,627	-5,467 Reduced 37.46%	9,129 $280,000
Q3 2022 Nov 04, 2022	BUY	$34.2 - $51.69 $38,509 - $58,202	1,126 Added 8.36%	14,596 $499,000
Q2 2022 Aug 01, 2022	BUY	$23.14 - $49.68 $20,594 - $44,215	890 Added 7.07%	13,470 $467,000
Q1 2022 May 10, 2022	BUY	$27.77 - $64.4 $50,430 - $116,950	1,816 Added 16.87%	12,580 $553,000
Q4 2021 Feb 08, 2022	BUY	$54.9 - $105.21 $372,606 - $714,060	6,787 Added 170.66%	10,764 $677,000
Q3 2021 Nov 12, 2021	SELL	$105.0 - $178.37 $70,770 - $120,221	-674 Reduced 14.49%	3,977 $419,000
Q2 2021 Aug 12, 2021	BUY	$125.11 - $180.0 $95,083 - $136,800	760 Added 19.53%	4,651 $824,000
Q1 2021 May 14, 2021	BUY	$126.27 - $191.71 $283,223 - $430,005	2,243 Added 136.1%	3,891 $519,000
Q4 2020 Feb 09, 2021	BUY	$81.94 - $135.34 $135,037 - $223,040	1,648 New	1,648 $223,000

123

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.55B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.